|
Jun 29
|
Evotec (EVO) Joins NURTuRE-AKI Consortium to Advance Kidney Injury Drug Discovery
|
|
Jun 26
|
Basic Materials Roundup: Market Talk
|
|
Jun 25
|
Sector Update: Health Care Stocks Mixed Premarket Wednesday
|
|
Jun 25
|
Evotec Joins NURTuRE-AKI Consortium to Gain Multi-Omics-Based Molecular Understanding of Acute Kidney Injury
|
|
May 12
|
European Stocks Estimated Below Intrinsic Value In May 2025
|
|
May 7
|
Evotec SE (EVO) Q1 2025 Earnings Call Highlights: Navigating Revenue Challenges and Embracing ...
|
|
May 7
|
Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis Treatments
|
|
May 6
|
Evotec SE Reports Q1 2025 results: Paving the Way for 2025 Growth in Soft Market Environment
|
|
Apr 10
|
Evotec SE to Announce Results for Financial Year 2024 on 17 April 2025
|
|
Apr 2
|
Is Evotec (EVO) the Best German Stock to Buy According to Hedge Funds?
|
|
Oct 1
|
Even after rising 11% this past week, Evotec (ETR:EVT) shareholders are still down 84% over the past three years
|
|
Sep 26
|
Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-Generation Cell Therapies
|
|
Sep 23
|
Evotec opens first European biologics facility in France
|
|
Sep 20
|
Just - Evotec Biologics Opens Cutting-Edge Biologics Facility - J.POD(R) Toulouse, France (EU)
|
|
Jul 31
|
Evotec SE's (ETR:EVT) largest shareholders are retail investors with 48% ownership, institutions own 36%
|
|
Jun 25
|
Just - Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
|
|
Jun 12
|
Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb
|
|
Jun 10
|
Evotec SE: Results of the Annual General Meeting 2024
|
|
Jan 22
|
Evotec SE: Invitation to Conference Call
|
|
Jan 22
|
UPDATE 1-Evotec says it promptly reported share trades withheld by former CEO
|